Use of Hepatoprotectors in Patients With Ovarian Cancer

Obshchaya Reanimatologiya - Russian Federation
doi 10.15360/1813-9779-2015-2-49-55
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FSBI SRIGR RAMS

Related search

Polypharmacy in Patients With Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2015English

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

Plasma Immune Analytes in Patients With Epithelial Ovarian Cancer

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2015English

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

New England Journal of Medicine
Medicine
2019English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Immunotherapy With Checkpoint Inhibitors in Patients With Ovarian Cancer: Still Promising?

Cancer
Cancer ResearchOncology
2019English

BRCA1andBRCA2mutations in Ovarian Cancer Patients From China: Ethnic-Related Mutations inBRCA1associated With an Increased Risk of Ovarian Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Palliative Care in Patients With Ovarian Cancer and Bowel Obstruction

Supportive Care in Cancer
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy